The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

riverd.com

Investors Count

3

River Diagnostics Funding, River Diagnostics Valuation & River Diagnostics Revenue

2 Fundings

River Diagnostics's latest funding round was a Series A for on November 28, 2007.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/28/2007

Series A

0

FY undefined

1

Other Investors

0

FY undefined

0

Date

11/28/2007

Round

Series A

Other Investors

Amount

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

Sources

1

0

River Diagnostics Investors

3 Investors

River Diagnostics has 3 investors. Erasmus MC Biomedical Fund invested in River Diagnostics's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/28/2007

11/28/2007

1
Series A

Venture Capital

Netherlands

00/00/0000

00/00/0000

TIIN Capital

Subscribe to see more

Venture Capital

Netherlands

BioPartner Start-up

Subscribe to see more

Government

Netherlands

First funding

11/28/2007

00/00/0000

Last Funding

11/28/2007

00/00/0000

Investor

TIIN Capital

BioPartner Start-up

Rounds

1
Series A

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Government

Location

Netherlands

Netherlands

Netherlands

You May Also Like

D
DERMING SRL

DermIng, an independent private research Institute, carries out a series of clinical trials to measure the activity and tolerance of skin care treatments and products, and also developers the very latest non-invasive diagnostic bio-engineering systems.

D
DIRAmed

DIRAmed is developing non-invasive meters that measure the levels of key constituents of the human body such as glucose, ketones, cholesterol, and therapeutic drugs. DIRAmed's meters will improve the process by which diabetics and other patients taking therapeutic drugs monitor the levels of components in blood and tissue. DIRAmed currently has investigational prototypes in clinical studies for use in improving tight glycemic control in hospital critical care continuous glucose monitoring applications. DIRAmed is also discussing other designs with selected strategic partners including the development of mobile units for personal use with or without connection to an insulin pump.

T
Truthtek

Truthtek is a spin-out company from Manchester Metropolitan University with a suite of software for the analysis of non-verbal behaviour in video streams of structured interviews. The technology combines latest psychological research in non-verbal communication with leading image recognition and analysis software. Potential applications include lie detection, where the technology is non-invasive and has shown 85% accuracy in initial trials. MTF has provided initial seed capital to the company to enable it to develop its commercial and market-entry strategy.

NeuroSky Logo
NeuroSky

NeuroSky is at the forefront of body and mind monitoring and analysis. Its technologies are at the core of innovative, wearable health and wellness consumer products. NeuroSky makes it possible for millions of consumers to capture and quantify critical health and wellness data so that they can effectively manage their mind and body health. NeuroSky delivers uniquely adaptable chips and algorithms that offer ECG multi-function cardio monitoring, and quantitive and interpretive algorithms in a powerful integrated, adaptable and extensible solution.

C
CryoPen

CryoPen is a developer and manufacturer of state-of-the art medical devices and aesthetic treatment systems. CryoPen is committed to delivering the most effective, and profitable solutions available to healthcare providers, physicians of all specialties, and medical spas. The company's product portfolio aims to enable physicians to provide a higher quality of care and offer their patients a more diverse array of treatments while generating a substantial revenue stream for their practice. CryoPen's product set addresses a multitude of treatment applications such as laser hair removal, skin rejuvenation, cryosurgery, cellulite reduction, vascular lesions, pigmented lesions, acne, psoriasis, fine lines & wrinkles, scar and tattoo removal, photo facials, and skin tightening. With a dedication to the research and development of technologically advanced devices and equipment, every CryoPen product is designed to create a better patient experience, consistent clinical outcomes, and economic impact on the bottom line of their practice.

m
m2m Imaging

Corp.m2m Imaging, with offices in USA and Australia produce's high-definition imaging and work flow solutions for life science applications in the MRI, PET, CT and SPECT analytical, preclinical and clinical research environments. m2m's MRI coil and accessory portfolio consists of products that have provided solutions to enable otherwise unobtainable results for research applications all over the world.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.